ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Pharmaceutical Preparations

Latest Price

$80.67

TTM P/E

Normalized P/E

Div Yield

Book Value

3.25

P/B Ratio

24.85

Valuation metrics

Base FCF: $152M (median of recent 5yr)

Growth: 5%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$20.80

74% downside

85.1% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	14.83M	$1.21B	10.51%	-3.33M	2026-06-30
Avoro Capital Advisors LLC	11.36M	$925.0M	8.05%	+655.6K	2026-06-30
FMR LLC	8.04M	$655.0M	5.70%	+773.2K	2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC	6.35M	$517.0M	4.50%	-794.8K	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	6.11M	$498.0M	4.33%	+78.5K	2026-06-30
STATE STREET CORP	5.69M	$464.0M	4.03%	-801.5K	2026-06-30
NORGES BANK	3.90M	$317.0M	2.76%	+2.19M	2026-06-30
Invesco Ltd.	3.88M	$316.0M	2.75%	+603.3K	2026-06-30
GEODE CAPITAL MANAGEMENT, LLC	3.53M	$298.0M	2.50%	-748.2K	2026-06-30
FRED ALGER MANAGEMENT, LLC	3.30M	$269.0M	2.34%	-40.6K	2026-06-30